REGENEUS LTD (ASX:RGS)
Industry: Classification Pending
Activity: Regenerative medicine.
77 Ridge Street GORDON NSW 2072
Ph: (02) 9499 8010    Fax: (02) 9499 8020
Duncan Thomson
Wed, 13 Nov 2013 1:30pm
Duncan Thomson, Head of Animal Health
Icon_lastIcon_nextIcon_previousIcon_first
Interim Results
Thu, 27 Feb 2014
Annual General Meeting
Wed, 27 Nov 2013
Disclosure Document Tue, 8 Jul 2014
Exclusive global rights for human cancer vaccine-Amended hdr Tue, 8 Jul 2014
RGS enters into agreement for US marketing trial for Kvax Mon, 30 Jun 2014
New treatment option for chronic neuropathic pain patients Wed, 14 May 2014
Appendix 4C - quarterly Thu, 17 Apr 2014
Ethics approval for procurement for off-the-shelf treatment Tue, 8 Apr 2014
Regeneus partners with Hennessy Research for Kvax Fri, 4 Apr 2014
HiQCell Joint Registry Results Wed, 26 Mar 2014
RGS to present at Regenerative Medicine Investor Day Fri, 21 Mar 2014
Appendix 3B Wed, 19 Mar 2014

Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. BRR Media does not claim any association with any company listed on this site.